HEADER HYDROLASE/INHIBITOR 29-APR-21 7MMB TITLE CRYSTAL STRUCTURE OF HCV NS3/4A D168A PROTEASE IN COMPLEX WITH NR01- TITLE 2 127 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NS3 PROTEASE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEPACIVIRUS C; SOURCE 3 ORGANISM_TAXID: 11103; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS NS3/4A PROTEASE, HEPATITIS C VIRUS, DRUG RESISTANCE, PROTEASE KEYWDS 2 INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX, HYDROLASE, KEYWDS 3 HYDROLASE-INHIBITOR COMPLEX, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.ZEPHYR,C.A.SCHIFFER REVDAT 3 18-OCT-23 7MMB 1 REMARK REVDAT 2 30-MAR-22 7MMB 1 JRNL REVDAT 1 16-MAR-22 7MMB 0 JRNL AUTH J.ZEPHYR,D.NAGESWARA RAO,S.V.VO,M.HENES,K.KOSOVRASTI, JRNL AUTH 2 A.N.MATTHEW,A.K.HEDGER,J.TIMM,E.T.CHAN,A.ALI,N.KURT YILMAZ, JRNL AUTH 3 C.A.SCHIFFER JRNL TITL DECIPHERING THE MOLECULAR MECHANISM OF HCV PROTEASE JRNL TITL 2 INHIBITOR FLUORINATION AS A GENERAL APPROACH TO AVOID DRUG JRNL TITL 3 RESISTANCE. JRNL REF J.MOL.BIOL. V. 434 67503 2022 JRNL REFN ESSN 1089-8638 JRNL PMID 35183560 JRNL DOI 10.1016/J.JMB.2022.167503 REMARK 2 REMARK 2 RESOLUTION. 1.99 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.18.2_3874 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.99 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.84 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 13556 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.223 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.950 REMARK 3 FREE R VALUE TEST SET COUNT : 671 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 23.8400 - 3.4000 1.00 2700 143 0.2121 0.2282 REMARK 3 2 3.4000 - 2.7000 1.00 2580 134 0.1710 0.2057 REMARK 3 3 2.7000 - 2.3600 1.00 2559 134 0.1705 0.2317 REMARK 3 4 2.3600 - 2.1400 1.00 2538 134 0.1533 0.2192 REMARK 3 5 2.1400 - 1.9900 0.99 2508 126 0.1596 0.2305 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.204 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.222 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.11 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.31 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 1503 REMARK 3 ANGLE : 1.051 2060 REMARK 3 CHIRALITY : 0.053 242 REMARK 3 PLANARITY : 0.006 261 REMARK 3 DIHEDRAL : 15.483 235 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7MMB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-APR-21. REMARK 100 THE DEPOSITION ID IS D_1000256500. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-JUL-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : HKL-3000 703X REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13596 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.990 REMARK 200 RESOLUTION RANGE LOW (A) : 23.840 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08800 REMARK 200 FOR THE DATA SET : 21.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.99 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.06 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.14000 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5VOJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM MES BUFFER PH 6.5, 4% (W/V) REMARK 280 AMMONIUM SULFATE, 20-26% PEG 3350 THE CRYOGENIC CONDITION IS 100 REMARK 280 MM MES BUFFER PH 6.5, 4% (W/V) AMMONIUM SULFATE, 20-26% PEG 3350, REMARK 280 15% ETHYLENE GLYCOL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.15800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 29.36550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.74600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 29.36550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.15800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.74600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 982 REMARK 465 SER A 985 REMARK 465 MET A 986 REMARK 465 ARG A 1180 REMARK 465 SER A 1181 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 987 CG CD CE NZ REMARK 470 LYS A 988 CG CD CE NZ REMARK 470 LYS A 989 CG CD CE NZ REMARK 470 SER A1001 OG REMARK 470 ASP A1003 CG OD1 OD2 REMARK 470 THR A1004 OG1 CG2 REMARK 470 GLU A1013 CG CD OE1 OE2 REMARK 470 GLU A1014 CG CD OE1 OE2 REMARK 470 GLN A1017 CG CD OE1 NE2 REMARK 470 GLN A1021 CG CD OE1 NE2 REMARK 470 ARG A1024 CG CD NE CZ NH1 NH2 REMARK 470 LYS A1026 CG CD CE NZ REMARK 470 GLN A1028 CG CD OE1 NE2 REMARK 470 LYS A1068 CG CD CE NZ REMARK 470 GLN A1089 CG CD OE1 NE2 REMARK 470 ARG A1092 CG CD NE CZ NH1 NH2 REMARK 470 ARG A1161 CG CD NE CZ NH1 NH2 REMARK 470 LYS A1165 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A1038 -168.36 -103.67 REMARK 500 THR A1038 -168.36 -104.74 REMARK 500 PHE A1043 -165.54 -165.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1203 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A1097 SG REMARK 620 2 CYS A1099 SG 112.7 REMARK 620 3 CYS A1145 SG 110.1 117.8 REMARK 620 4 HIS A1149 ND1 125.6 92.7 97.0 REMARK 620 N 1 2 3 DBREF1 7MMB A 1004 1181 UNP A0A0B4WYC6_9HEPC DBREF2 7MMB A A0A0B4WYC6 4 181 SEQADV 7MMB HIS A 982 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7MMB MET A 983 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7MMB ALA A 984 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7MMB SER A 985 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7MMB MET A 986 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7MMB LYS A 987 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7MMB LYS A 988 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7MMB LYS A 989 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7MMB GLY A 990 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7MMB SER A 991 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7MMB VAL A 992 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7MMB VAL A 993 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7MMB ILE A 994 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7MMB VAL A 995 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7MMB GLY A 996 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7MMB ARG A 997 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7MMB ILE A 998 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7MMB ASN A 999 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7MMB LEU A 1000 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7MMB SER A 1001 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7MMB GLY A 1002 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7MMB ASP A 1003 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7MMB GLU A 1013 UNP A0A0B4WYC LEU 13 CONFLICT SEQADV 7MMB GLU A 1014 UNP A0A0B4WYC LEU 14 CONFLICT SEQADV 7MMB GLN A 1017 UNP A0A0B4WYC ILE 17 CONFLICT SEQADV 7MMB GLU A 1018 UNP A0A0B4WYC ILE 18 CONFLICT SEQADV 7MMB GLN A 1021 UNP A0A0B4WYC LEU 21 CONFLICT SEQADV 7MMB SER A 1047 UNP A0A0B4WYC CYS 47 CONFLICT SEQADV 7MMB LEU A 1052 UNP A0A0B4WYC CYS 52 CONFLICT SEQADV 7MMB THR A 1072 UNP A0A0B4WYC ILE 72 CONFLICT SEQADV 7MMB GLN A 1086 UNP A0A0B4WYC PRO 86 CONFLICT SEQADV 7MMB SER A 1159 UNP A0A0B4WYC CYS 159 CONFLICT SEQADV 7MMB ALA A 1168 UNP A0A0B4WYC ASP 168 ENGINEERED MUTATION SEQADV 7MMB SER A 1179 UNP A0A0B4WYC MET 179 CONFLICT SEQRES 1 A 200 HIS MET ALA SER MET LYS LYS LYS GLY SER VAL VAL ILE SEQRES 2 A 200 VAL GLY ARG ILE ASN LEU SER GLY ASP THR ALA TYR ALA SEQRES 3 A 200 GLN GLN THR ARG GLY GLU GLU GLY CYS GLN GLU THR SER SEQRES 4 A 200 GLN THR GLY ARG ASP LYS ASN GLN VAL GLU GLY GLU VAL SEQRES 5 A 200 GLN ILE VAL SER THR ALA THR GLN THR PHE LEU ALA THR SEQRES 6 A 200 SER ILE ASN GLY VAL LEU TRP THR VAL TYR HIS GLY ALA SEQRES 7 A 200 GLY THR ARG THR ILE ALA SER PRO LYS GLY PRO VAL THR SEQRES 8 A 200 GLN MET TYR THR ASN VAL ASP LYS ASP LEU VAL GLY TRP SEQRES 9 A 200 GLN ALA PRO GLN GLY SER ARG SER LEU THR PRO CYS THR SEQRES 10 A 200 CYS GLY SER SER ASP LEU TYR LEU VAL THR ARG HIS ALA SEQRES 11 A 200 ASP VAL ILE PRO VAL ARG ARG ARG GLY ASP SER ARG GLY SEQRES 12 A 200 SER LEU LEU SER PRO ARG PRO ILE SER TYR LEU LYS GLY SEQRES 13 A 200 SER SER GLY GLY PRO LEU LEU CYS PRO ALA GLY HIS ALA SEQRES 14 A 200 VAL GLY ILE PHE ARG ALA ALA VAL SER THR ARG GLY VAL SEQRES 15 A 200 ALA LYS ALA VAL ALA PHE ILE PRO VAL GLU SER LEU GLU SEQRES 16 A 200 THR THR SER ARG SER HET ZJG A1201 101 HET EDO A1202 10 HET ZN A1203 1 HET EDO A1204 10 HET EDO A1205 10 HET EDO A1206 10 HET SO4 A1207 5 HET SO4 A1208 5 HET SO4 A1209 5 HETNAM ZJG CYCLOBUTYL {(2R,4S,6S,12Z,13AS,14AR,16AS)-2-[(7- HETNAM 2 ZJG METHOXY-3-METHYLQUINOXALIN-2-YL)OXY]-14A-[(1- HETNAM 3 ZJG METHYLCYCLOPROPANE-1-SULFONYL)CARBAMOYL]-5,16-DIOXO-1, HETNAM 4 ZJG 2,3,5,6,7,8,9,10,11,13A,14,14A,15,16,16A- HETNAM 5 ZJG HEXADECAHYDROCYCLOPROPA[E]PYRROLO[1,2-A][1, HETNAM 6 ZJG 4]DIAZACYCLOPENTADECIN-6-YL}CARBAMATE HETNAM EDO 1,2-ETHANEDIOL HETNAM ZN ZINC ION HETNAM SO4 SULFATE ION HETSYN EDO ETHYLENE GLYCOL FORMUL 2 ZJG C37 H48 N6 O9 S FORMUL 3 EDO 4(C2 H6 O2) FORMUL 4 ZN ZN 2+ FORMUL 8 SO4 3(O4 S 2-) FORMUL 11 HOH *112(H2 O) HELIX 1 AA1 GLY A 1012 GLY A 1023 1 12 HELIX 2 AA2 VAL A 1055 GLY A 1060 1 6 HELIX 3 AA3 SER A 1133 LEU A 1135 5 3 HELIX 4 AA4 VAL A 1172 SER A 1179 1 8 SHEET 1 AA1 7 TYR A1006 GLN A1009 0 SHEET 2 AA1 7 VAL A 993 ASN A 999 -1 N ASN A 999 O TYR A1006 SHEET 3 AA1 7 VAL A1033 SER A1037 -1 O ILE A1035 N VAL A 995 SHEET 4 AA1 7 THR A1042 ILE A1048 -1 O ALA A1045 N GLN A1034 SHEET 5 AA1 7 VAL A1051 THR A1054 -1 O TRP A1053 N THR A1046 SHEET 6 AA1 7 LEU A1082 GLN A1086 -1 O TRP A1085 N LEU A1052 SHEET 7 AA1 7 TYR A1075 ASN A1077 -1 N ASN A1077 O LEU A1082 SHEET 1 AA2 7 ASP A1103 VAL A1107 0 SHEET 2 AA2 7 VAL A1113 ARG A1118 -1 O ILE A1114 N LEU A1106 SHEET 3 AA2 7 ARG A1123 PRO A1131 -1 O SER A1125 N ARG A1117 SHEET 4 AA2 7 VAL A1163 PRO A1171 -1 O ALA A1164 N ARG A1130 SHEET 5 AA2 7 ALA A1150 THR A1160 -1 N VAL A1158 O ALA A1166 SHEET 6 AA2 7 PRO A1142 LEU A1144 -1 N LEU A1143 O VAL A1151 SHEET 7 AA2 7 ASP A1103 VAL A1107 -1 N TYR A1105 O LEU A1144 LINK SG CYS A1097 ZN ZN A1203 1555 1555 2.33 LINK SG CYS A1099 ZN ZN A1203 1555 1555 2.32 LINK SG CYS A1145 ZN ZN A1203 1555 1555 2.31 LINK ND1 HIS A1149 ZN ZN A1203 1555 1555 2.02 CRYST1 54.316 59.492 58.731 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018411 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016809 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017027 0.00000